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Summary 
We  have  examined  signaling  roles  for  CD54  intercellular  adhesion  molecule  1  and  major 
histocompatibility complex (MHC) II as contact ligands during T  help for B cell activation. 
We used a T helper 1 (Thl)-dependent helper system that was previously shown to be contact 
as well as interleukin 2 (IL-2) dependent to demonstrate the relative roles of CD54,  MHC II, 
and CD40 signaling in the events leading to the induction of B cell proliferation and responsiveness 
to IL-2. Paraformaldehyde-fixed activated Thl-induced expression of IL-2Kot, IL-2Kfl,  and B7, 
and upregulated MHC II and CD54 on B cells. Anti-CD54 and MHC II mAbs as well as a 
CDScc-CD40 ligand (L) soluble construct inhibited both the T-dependent induction of Ig secretion, 
and B cell phenotypic changes. We then compared the effects of activated Thl cells with that 
of cross-linking these molecules. Cross-linking of CD54 and MHC II resulted in the upregulated 
expression of MHC II and of CD54 and B7, respectively, analogous to the effect of fixed activated 
Thl cells. B7 expression was further enhanced by co-cross-linking CD54 and MHC II. Cross- 
linking of CD40 achieved comparable effects. Strikingly, cross-linking ligation of CD54 and 
MHC II in the presence of IL-5 induced expression of a functional IL-2K on small resting B 
cells.  By contrast  CD40  ligation,  which induced B  cell proliferation,  did  not  induce IL-2 
responsiveness.  These data show that CD40 ligation is necessary but may not be sufficient for 
B cell differentiation and identify CD54 and MHC II as contact ligands that can complement 
CD40  signaling in the generation of T-dependent B cell responses to IL-2. 
T 
he induction of Ab responses towards the majority of 
Ags requires help from Th lymphocytes. B cells present 
antigenic peptides to CD4 + Th cells whose TCK specificity 
is directed towards such peptides in the context of class II 
MHC (1-3). Cell contact occurs during MHC-cognate B-T 
interactions, and signaling events resulting from this contact 
have been shown to promote B cell entry into cycle and re- 
sponsiveness  to T-derived cytokines (4-8).  The role of cell 
contact has been extensively studied (reviewed in 6-8), using 
allogeneic T  cells (9-13),  Th membranes (14-16),  and Th 
cells whose cytokine production was inhibited (17). The de- 
pendence on antigen recognition by the T  cell confers an- 
tigen specificity on otherwise nonspecific helper signals (6). 
The nature of the receptor/ligand pairs that mediate con- 
tact signaling during T  help for B cells has been the focus 
of extensive research. Recent cloning of a T  cell ligand for 
CD40 by a number of laboratories demonstrated two char- 
acteristics of this molecule that satisfied requirements for its 
being critical to signal transduction in contact help (6, 18-20). 
First,  the CD40-1igand (CD40-L) 1 molecule is not expressed 
by resting T  cells, whether they be cloned or ex vivo, but 
is transiently induced by TCK/CD3  signaling (6,  18-21). 
Second, antibodies against CD40-L, or constructs of soluble 
CD40 with IgG constant region domains inhibited T-depen- 
dent B cell help (18-21),  and individuals who genetically lack 
expression of the CD40-L molecule suffer an immunodefi- 
ciency in which antibody responses do not mature to IgG 
production (22-25). Demonstrations that anti-CD40 mAbs 
and cells transfected with the CD40-L induce B cell prolifer- 
ation (6, 20, 26), and that upregulation of B7 expression on 
B cells can be induced through a CD40-dependent signal (27) 
and that anti-CD40 mAbs rescued germinal center B cells 
from apoptosis (28) all contribute to acceptance of CD40-L 
1 Abbreviations used in  this paper: CD40-1igand, CD40-L; LFA-1, 
lymphocyte  function-associated  antigen 1; SI, stimulation index. 
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tions support a model for B cell activation whereby antigen 
presentation to T  cells induces CD40-L expression,  which 
then signals B cells through CD40. Experimentally the re- 
quirement for antigen presentation can be bypassed through 
activation of T cells by anti-TCR/CD3, thereby facilitating 
direct application of T helper effector functions (6-8). In these 
systems contact help suffices to induce high rate Ig secretion. 
Resting T  cells that do not express CD40-L are ineffective 
as contact helpers (6). However expression of CD40-L is not 
by itself sufficient to confer helper activity, at least on T cells 
immediately isolated to culture (30). 
The above model does not include a signaling role for other 
adhesion molecules. However, under circumstances where 
CD40-L levels are low (e.g., on primary or ex vivo T  cells 
[30]) one might envisage an accessory role for other receptor/ 
ligand pairs. Candidate ligands on routine B cells include CD54 
and MHC II (6,  31, 32).  Although levels of expression  of 
adhesion molecules such as lymphocyte function-associated 
antigen 1 (LFA-1) are not profoundly affected by T cell acti- 
vation, there is inferential evidence for conformational changes 
that may modify their biological activity e.g., through al- 
tered avidity (33,  34).  There is, therefore, an a priori case 
for consideration of LFA-1 as a helper ligand on T cells,  at 
least on the basis of its activation dependence for effect. Also, 
a T-dependent rise in intracellular calcium that was induced 
in a human B cell line during peptide presentation to a T 
cell done was inhibited by mAb to CD18 on the T  cell or 
CD54 on the B cell, further demonstrating signaling through 
this ligand pair during T-B interactions (35). Ligation of  MHC 
II is intimately associated with T cell activation, and numerous 
reports have described signaling via MHC II on B cells (36, 
37). In previous work we described a Thl clone that induced 
a high frequency of small resting allogeneic B cells to enter 
cycle and secrete Ig (9, 10). The T-B interaction was contact 
dependent, and did not involve either Ag or MHC recogni- 
tion by the T cells. Significantly, this response was inhibited 
by anti-LFA-1 and CD54 mAbs that did not affect B cell 
responses  to mitogens, T  cell activation to cytokine secre- 
tion, or the formation of T-B conjugates (31). 
We have now further examined the role of  CD54 and MHC 
II in contact help and have compared it with the effects gener- 
ated by the ligation of CD40. We show a signaling role for 
CD54 and MHC II in the induction of cytokine receptors. 
This may complement help provided to B cells through CD40 
ligation, or independently of the latter, might constitute a 
possible  alternative pathway of B cell activation. 
Materials and Methods 
mAbs and Soluble Constructs.  mAbs used were F23.1 (mouse 
IgG2~ anti-TCR V38) (38), 30H12 (rat IgG2b anti-Thy-l.2) (39), 
F7D5 (mouse IgM anti-Thy-l.2) (40), KT4 (rat IgG2b anti-TCR 
V34) (41), TRFK-5  (rat IgGa antimurine Ib5) (42), 172.4 (rat 
IgM antimurine CD4) (43), HO2.2 (mouse IgM anti-Lyt-2.2)  (44), 
PC61 (rat IgG1 antimurine IL-2Rc~) (43), TM~I (rat IgG2b an- 
timurine IL-2R3) (45), 145-2Cll (hamster IgG antimurine CD3e) 
(46), $4B6 (rat IgG2~ antimurine Ib2) (47), 53-6.7.2 (rat IgG2~  an- 
timurine Lyt-2 [CD8o~]) (39), GK1.5 (rat IgG2b antimurine CD4) 
(48), P7/7.1 (rat IgG2b antimurine I-A, I-E) (49), YN1/1.7.4.1 (rat 
IgG2b antimurine CD54 intercellular adhesion molecule 1 [ICAM- 
1]) (50). Antibodies  were either used as supernatants  or were affinity- 
purified from culture supernatants using Protein G-Sepharose (Phar- 
macia LKB, Montr6al, Qu6bec, Canada). A hybridoma secreting 
soluble mCD40-L-mCD8~  chimeric protein  (26) was  kindly 
provided by Dr. P. Lane (Basel Institute for Immunology, Basel, 
Switzerland), and chimeric molecules  expressing human-IgG~  con- 
stant domains and extracellular  portions of the mouse CTLA4 gene 
(51) or mouse CD40 gene were kindly provided by Dr. P. Linsley 
(Bristol  Myer  Squibb,  Seattle, WA)  and  by  Dr.  M.  Kehry 
(Boehringer Ingelheim Corp., CT), respectively. 
B Cells.  Spleen  cells from C57B1/6 female  mice (Charles River 
Laboratories, St-Constant, Qu6bec, Canada) were depleted of red 
blood cells by hypotonic  lysis,  then depleted  ofT cells by two rounds 
of treatment with anti-T cell mAb (172.4 + F7D5 + HO2.2) and 
rabbit complement (Cedarlane, Hornby, Ontario, Canada). Cells 
were then ffactionated on discontinuous Percoll (Pharmacia LKB) 
gradients. Cells that sedimented between 1.08 and 1.09 g/ml were 
used in all assays. They were <1% Thy-l.2 +  , ;>90% surface Ig +  , 
and homogeneously small. 
T Cells.  The CBA-derived  hapten-specific  CD4 §  V38 § Thl 
cell clone E9.D4 (9) was used after periods of 2-5 d resting culture, 
in the absence of Ag, filler cells, or Ib2. Cells were mycoplasma- 
free and irradiated (2,000 rad) before use in experiments. Screening 
for  mycoplasma was  carried-out  by  6-methylpurinedeoxyribo- 
side cytotoxicity (Mycotect; GIBCO BILL, Burlington, Ontario, 
Canada). When needed, cells were fixed using 0.8% paraformalde- 
hyde (Sigma Chemical Co., St. Louis, MO) followed  by 0.2 M ly- 
sine (Sigma Chemical Co.). 
B Cell Activation.  B-T cocultures  were established  in RPMI 1640 
(Flow Laboratories, Mississauga, Ontario, Canada) supplemented 
with 5% FCS (Flow), 2 mM L-glutamine (GIBCO BILL), 5  x 
10 -s M 2-ME (Sigma Chemical Co.), and penicillin (100 U/ml)- 
streptomycin (100 ~.g/ml) (GIBCO BRL), in triplicate, by the ad- 
dition of 10  s B cells to 6  x  104 irradiated E9.D4 cells in F23.1- 
coated microwells (10/~g/ml in PBS) with or without cytokines. 
When using fixed T cells, B-T cocultures were set up in round- 
bottom microplates. In blocking assays,  soluble  mAbs or constructs 
were added  at the onset of the B-T coculture.  LPS (Salmonella  abortus; 
Difco, Detroit,  Michigan) was added at 20 #g/ml. Purified anti- 
CD54 (YN1/1.71.1), anti-MHC II (P7/7.1), or anti-CD8ot (53- 
6.7.2) were either coupled to biotin  using biotinamidocaproate 
N-hydroxy-succinimide  ester (Sigma Chemical Co.) or coupled to 
CNBr-activated Sepharose  4B beads (Pharmacia  LKB) at I mg/ml. 
Biotinylated mAb (10/~g/ml) and streptavidin (Sigma Chemical 
Co.) or coupled beads (20/~1 from a 20% suspension) were added 
to 10  s B cells, in triplicate cultures, with or without cytokines or 
CD8cc-CD40-L soluble construct. 
Cytokines.  Superuatants from  the  X63-Ag8-653-mlb2  and 
-mIL-5 plasmacytomas  were used as sources  of IL-2 and Ib5, respec- 
tively (52). The IL-2  content of supernatants was calibrated  by bio- 
assay using the CTLL-6 line. To assess 1I.-5 activity, the induction 
of Ig secretion  by resting B cells  was measured  by ELISA. Superna- 
tants  were compared to  recombinant  routine  IL-5 (Genzyme, 
Markham, Ontario, Canada) and contained ,o500 U/ml IL-5. The 
addition of the anti-IL-5 mAb TRFK-5 confirmed the specificity 
of these responses. 
Assessment of B  Cell Activation.  Entry into cell cycle was as- 
sessed by measurement of incorporation of [3H]thymidine  (specific 
activity 6.7/~Ci/mM; ICN Biomedicals  Canada Inc., Mississauga, 
Ontario, Canada) after a 6-h pulse of 0.5/~Ci/microculture at 2 d 
of  culture. Ig secretion was assessed  using a modified ELISA assay. 
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volume, after which the total Ig content of 50 #1 aliquots of super- 
natant was measured by ELISA, using peroxidase-coupled sheep 
anti-mouse Ig (Bio/Can Scientific,  Toronto, Ontario, Canada), and 
goat anti-mouse Ig (Antibodies, Inc., Davis, CA) as a capture re- 
agent. This ELISA  was equivalently  sensitive to IgM, IgGl, IgGh, 
IgG2b, and IgG3. Conversion of optical densities (405 ~/m) to Ig 
concentrations was by SLT 400 AT ELISA software  (Fisher Scientific, 
Montr6al, Qu6bec, Canada) using a titration  of affinity-purified 
F23.1 mAb as reference. The sensitivity range for this assay was 
between 250 and 1 7/g/ml. This ELISA  measures  levels oflg secre- 
tion equivalent to those detected in a Protein A plaque assay (9). 
Flow Cytometry.  Cells  were collected from culture, washed, and 
filtered through a nylon mesh (B. & S.H. Thompson, Ville Mont- 
Royal, Quebec, Canada) to remove Sepharose beads where appro- 
priate. Cells were then stained by successive 20-min incubations 
at 4~  with biotinylated mAb or mAb directly coupled to FITC, 
at concentrations ranging between 5 and 20 #g/ml. Secondary  re- 
agents used were PE (Southern Biotechnology Associates, Bir- 
mingham, AL) or FITC-coupled streptavidin (Bio/Can Scientific). 
mAb were fluoresceinated  using FITC-Celite  (Sigma  Chemical  Co.). 
Fluorescence was analyzed using a FACScan  |  (Becton-Dickinson 
Canada Inc., Mississauga, Ontario, Canada). Dead cells were ex- 
cluded on acquisition  by a combination  of  propidium iodide staining 
and side scatter gating. 
Results 
Activated Thl cells induce B cell proliferation and high 
rate Ig secretion.  This is dependent on contact between T 
and B cells, and the induction of Ig secretion is IL-2 depen- 
dent (9, 10). In previous studies,  anti-CD54 and anti-MHC 
II mAbs partially inhibited T-dependent B cell proliferation, 
and strongly inhibited Ig secretion  (31). We have previously 
shown that small resting B cells do not respond to IL-2 and 
that neither mR.NA for or surface expression of IL-2R pro- 
teins are detectable on the small resting B cells that we study 
(reference 33 and Fig.  1, A  and B). This Thl system there- 
fore provides us the opportunity to examine induction rather 
than upregulation of a cytokine receptor;  that is to say, a 
qualitative rather than quantitative effect. 
We first characterized  B cell phenotype changes induced 
by T contact, and the effects of CD54, MHC II, and CD40 
ligation on these. 
Contact with Activated T Cells Upregulates IL-2 Receptors and 
Other Surface Markers on B Cells.  Fig. 1 shows the effect of 
2 d  T-B coculture on the expression  of IL-2 receptor and 
other molecules by B cells. Paraformaldehyde-fixed  activated 
T  cells induced upregulation of both IL-2Ko~ and/3 chains 
(Fig.  1, A, B, F, and G), peak fluorescence increasing by 1 
and 1/2 log over background, respectively. The level of ex- 
pression  of IL-2R.o~ was equivalent to that induced by LPS 
(53,  54). 
Both MHC II and CD54 were also upregulated. In Fig. 
1 the level of expression  of MHC II increased from a peak 
fluorescence intensity of 30 to 200, and the peak fluorescence 
intensity for CD54 increased from 350 to 900. Comparable 
upregulations were observed  in other experiments. Expres- 
sion of the costimulator molecule B7 on B cells was induced 
from undetectable levels by coculture with activated T cells 
(Fig.  1).  Supernatants from activated  Thl cells did not in- 
duce either chain of the IL-2R on B cells, and it was previ- 
ously shown that such supernatant did not induce MHC II 
upregulation (9).  Upregulation of these molecules  was de- 
tectable  after overnight coculture, usually as strongly as at 
2 d as in Fig. 1. For comparison of surface phenotype changes 
with proliferative  responses  and responses  to cytokines we 
routinely assessed phenotype changes at 2 d. 
T-dependent Induction of Activation Markers on B Cells Is In- 
hibited by Blocking CD54, MHC II, and CD40,  We then as- 
sessed the effects of reagents directed at CD54  and MHC 
II on the B cell surface phenotype changes induced by T con- 
tact. Both mAbs abrogated IL-2R/3 expression. The upregu- 
lation of IL-2Roe was inhibited by both mAbs and there was 
B7 
E 
Figure  1.  Contact-dependent  induction  of IL-2K,  MHC II, CD54, and B7 on B cells. B cells  were  cultured  either  alone  (A-E) or with paraformaldehyde- 
fixed, activated  Thl cells (F-J). After 2 d, cells were collected, washed and stained  for IL-2Ro((PC61), IL-2K3 (TM/31), and CD54 (YN1/1.7.4.1), 
using biotinylated  mAbs and PE-coupled streptavidin. MHC II was stained  using FITC-coupled  P7/7.1. B7 was detected  using CTLA4-HulgG1  and 
FITC-coupled F(ab')2 goat anti-human  Ig(G + A + M). Profiles  show fluorochrome  controls (solid) and mAb staining  (open). T cells were electroni- 
cally gated out. Dead cells were excluded  by propidium iodide staining and side scatter gating. 
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Figure  2.  CD54, MHC II, and 
CD40 blockade inhibits B cell acti- 
vation. B cells were cultured with 
fixed Thl cells either alone (control), 
or with the addition of anti-MHC 
II or anti-CD54  (10 ~g/ml),  or 
with the CDSoL-CD40-L soluble 
construct (25% supernatant), and 
stained after 2 d in culture as de- 
scribed for Fig. 1. The effects  of  anti- 
MHC II and anti-CD54 being the 
same, only those generated by the 
anti-MHC II mAb are shown. The 
presence of anti-MHC II or -CD54 
mAbs in  culture  impeded subse- 
quent visualization of these mole- 
cules, and are therefore not shown. 
no significant effect of either mAb on MHC II or B7 expres- 
sion (Fig. 2). However, anti-MHC II almost completely in- 
hibited the upregulation of CD54.  Isotype-matched control 
mAbs (anti-V/~4) did not inhibit.  The combination of both 
mAb induced the same effect as each mAb alone (not shown). 
The effects of anti-CD40 reagents were similar, with a few 
exceptions. The CD8ol-CD40-L construct inhibited to back- 
ground  levels the upregulation  of IL-2/L8 and  IL-2Rcz in- 
duced by activated Thl on B cells. Expression of CD54 was 
reduced by half a log by CDSot-CD40-L,  and B7 expression 
was slightly inhibited. MHC II fluorescence was not affected 
by CD8oL-CD40-L. A control plasmacytoma (SP2/0) super- 
natant  had  no  effect. 
T-dependent B Cell Entry into Cycle and Differentiation Is In- 
hibited by Reagents against CD54, MHC II, and CD40.  Fig. 
3 A  confirms previous results showing that anti-CD54  and 
anti-MHC II inhibit T-dependent B cell activation. Whereas 
an isotype-matched control mAb (anti-Thy-l.2) reduced Ig 
secretion from 220  _+  10 ng/ml to  140  +  50 ng/ml,  anti- 
MHC  II reduced the response to 60  +  1 ng/ml  and  anti- 
CD54 to 40  +  10 ng/ml.  In a separate experiment,  the in- 
duction oflg secretion was reduced by 65% when both mAb 
were used in combination,  compared with 25-40%  reduc- 
tion by each mAb alone. In agreement with previous results, 
proliferative responses to optimally activated T  cells were less 
strongly and more variably affected. Addition of an isotype 
matched anti-CD4 mAb gave similar results to the effect pro- 
duced by anti-MHC II (not shown) when using fixed acti- 
vated T  cells.  None of the mAb used had any effect on re- 
sponses to LPS. 
Inclusion of CDScz-CD40-L in T-B cocultures  strongly 
inhibited B  cell responses  (Fig.  3, B  and C).  There was no 
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Figure 3.  T-dependent  induction 
of B cell entry into  cycle and Ig 
secretion  is  inhibited  by  CD54, 
MHC II, and CD40 blockade. B 
cells were cocultured with activated 
Thl cells. Controls included T cells 
alone (7), B cells alone (B) and LPS 
(20 ~g/ml).  For the Ig secretion 
data, LPS responses are shown as 
50% of the final value. Incorpora- 
tion of [3H]TdR was measured at 
2 d (B) and high rate Ig secretion 
by ELISA at 4-5 d (.4 and C). In A, purified anti-CD54,  anti-MHC  II, or anti-Thy 1.2 mAbs were added at 10/~g/mL at the initiation of culture 
and Ig secretion measured at 4 d. CD&x-CD40-L  was added at the initiation of culture as 25% hybridoma supernatant, with supernatant from the 
SP2/0 plasmacytoma as control (SP2/0 Sn). Data in all panels represent means of triplicate cultures. Bars show SD. 
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3), and the construct did not inhibit the response of B cells 
to LPS (not shown). This construct, as well as the other re- 
agents used in blocking assays, did not inhibit T cell activa- 
tion, as assessed by lack of effect on IL-2 secretion in response 
to anti-TCR stimulation. Proliferative responses were not to- 
tally inhibited by CD40 blocking, raising the possibility that 
other molecules are also implicated in the induction by T 
cells of this B cell response. 
Induction of Functional IL-2R by CD54 and MHC II Liga- 
tion.  When CD54  and MHC II were co-cross-linked by 
mAbs coupled to Sepharose beads,  immunoglobulin secre- 
tion was induced by mixtures of IL-2 and IL-5 (Fig. 4 A). 
There was no augmentation of the usual low-level response 
to IL-5 alone, nor any response to IL-2 alone (Fig. 4 A). CD54 
and MHC II co-cross-linking with Sepharose-coupled mAbs 
enhanced expression  of IL-2Roe over that induced by IL-5 
and induced IL-2R3 (Fig. 4 B). These responses were there- 
fore IL-2-driven. IL-5 by itself induces IL-2R,  oe on B cells, 
but does not induce IL-2 responsiveness, and was previously 
shown to synergize with LPS in the induction of functional 
IL-2 receptors  on B cells (53, 55). By contrast to CD54 and 
MHC II, cross-linking of CD40 using the CDSoe-CD40-L 
construct (26) and anti-CDS-coupled Sepharose beads, did 
not induce responsiveness to IL-2 either alone or in presence 
of IL-5  (not  shown).  The  cross-linking  ability  of anti- 
CDS-coupled beads was independently confirmed by immu- 
noprecipitation of CD8 from lymph node T  cells. Cross- 
linking CD40 using CD8ol-CD40-L and biotinylated anti- 
CD8 with streptavidin was similarly ineffective at inducing 
IL-2 responses. 
IL-2Roe was slightly upregulated by CD40 ligation (not 
as strongly as IL-5, LPS, or activated Thl cells) but this was 
not sufficient to induce responsiveness  to IL-2 (see Fig. 4). 
The combination of CD40 ligation with IL-5 did not aug- 
ment IL-2Rot induction by IL-5, and there was no detect- 
able effect of either treatment on levels of expression  of IL- 
2R~.  Cross-linking CD54  or MHC II using biotinylated 
mAb and streptavidin did not affect expression  of IL-2R.c~ 
or IL-2R3. 
Effects of CD54, MHC II, and CD40 Ligation on B Cell 
Surface Phenotype.  We also analyzed the effect  of contact 
ligand cross-linking on the expression  of MHC II, B7, and 
CD54.  We used biotinylated reagents and streptavidin as a 
cross-linker both for comparison between treatments and to 
facilitate coaggregation of B cell ligands. Cross-linking of 
CD54 upregulated MHC II expression on B cells (Fig. 5 A), 
but did not affect B7. MHC II cross-linking induced small 
increases in CD54 and B7. Neither cross-linking of CDlla 
or CD18, both isotype-matched mAbs, induced these effects. 
Cross-linking of CD40 upregulated both MHC II and B7 
on B cells, as has previously been described (27) (Fig.  5 B). 
The upregulation of B7 was enhanced by the inclusion of 
IL-5 (Fig. 5 B), which by itself did not affect B7 expression. 
IL-5 also  synergized with CD40 cross-linking to increase 
CD54 upregulation. Effects of CD40 cross-linking were not 
reproduced by SP2/0 supernatant, or by anti-CDSc~,  with 
or without streptavidin. 
We then further examined the effects of coaggregating pairs 
of contact ligands.  Co-cross-linking CD54 with MHC II 
induced a greater increase in B7 level than MHC II alone, 
and this was enhanced by IL-5 (Fig. 5 A). These levels were 
comparable to those obtained by cross-linking CD40 and were 
not further enhanced by co-cross-linking CD54 and MHC 
II with CD40. Coaggregation of CD40 with CD54 or MHC 
II did not potentiate the phenotypic changes induced by CD40 
ligation. The inclusion of IL-5 in these incubations had no 
effect beyond that of CD40 ligation alone. 
Although CD40 seemed more potent than CD54 or MHC 
II  alone  at  inducing  activation-related B  cell  phenotype 
changes,  coligation of CD54 with MHC II amplified the 
effects of these ligands and generated signals comparable to 
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Figure 4.  Cross-linking  MHC II 
with  CD54 using Sepharose- 
coupled mAbs with II.~2 and IL-5 
induces a functional IL-2K on B 
cells. (A) B cells  were  cultured  with 
Sepharose  beads coupled  with anti- 
MHC II and CD54, in the absence 
(medium alone) or presence  of IL-2 
(40 U/ml) and/or IL-5 (25% plas- 
macytoma  supernatant). High rate 
Ig secretion  was measured  at 4 d by 
ELISA. Data are shown as means 
of triplicate  cultures,  bars show  SD. 
(B)  Expression of  IL-2KB and 
Ib2Kc~ on B cells cultured for 2 d 
with IL-2 +  IL5 and Sepharose 
beads coupled with anti-MHC II 
and anti-CD54. Solid  profiles  show 
staining  controls,  open  profiles  show 
IL-2R stainings. The data are rep- 
resentative of three different ex- 
periments. 
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Figure  5.  B cell surface phenotype changes induced through cross-linking of CD54,  MHC II and CD40.  (Panel A) Biotinylated anti-CD54 was 
cross-linked on B cells with streptavidin, and surface expression of MHC It measured after 2 d, as described for Fig. 1. (A) Expression of MHC II 
on CD54 cross-linked (CD54; open) vs. unstimulated (uns; solid) B cells. (B-D) CD54 was co-cross-linked with MHC II using biotinylated mAbs 
and streptavidin. Expression of B7 (open) vs. fluorochrome controls (solid), on (B) Unstimulated; (C) CD54 and MHC II co-cross-linked; (D) CD54 
and MHC II co-cross-linked B cells, plus IL-5. (Panel B) CD40 was cross-linked on B cells by the addition of CDSc~-CD40-L, biotinylated anti-CD8oe 
mAb and streptavidin. IL-5 was added as 25% supernatant from a transfected plasmacytoma, which contained -o500 U/ml IL-5. Expression of MHC 
II, CD54, and B7 on B cells that were either unstimuiated, CD40 Iigated, or CD40 ligated in presence  of IL-5, were measured at 2 d as described for Fig. 1. 
those induced by CD40.  Furthermore,  coligation of CD54 
and MHC  II delivers signals that are very distinct from that 
generated through CD40, in that functional IL-2K could not 
be upregulated  through  binding  of this  ligand. 
Entry  of B  Cells  into  Cycle Induced through  CD40  Cross- 
linking.  To further examine the relative roles of CD54, MHC 
II and CD40 in B cell activation, we assessed their involve- 
ment in inducing B cell entry into cycle. Cross-linking CD40 
using CD8oe-CD40-L and biotinylated anti-CD8 with strep- 
tavidin induced significant thymidine incorporation.  Stimu- 
lation indices of 15-20 were obtained,  over background re- 
sponses of <200 cpm. This is consistent with results of others 
who have used the same construct  (26) (Table 1).  Coaggre- 
gation of CD54 and MHC  II only induced a 1.5-3-fold in- 
crease in  thymidine  incorporation.  Other  modes  of cross- 
linking the molecules (plastic-adsorbed or Sepharose-coupled 
mAbs) were no more effective than using biotinylated mAbs. 
These results indicate a primary signaling role for CD54 
and MHC II in contact help, in the induction of a functional 
IL-2K on B cells. There is a fundamental distinction between 
CD54,  MHC  II, and  CD40,  in that  the latter on its own 
induced entry into cycle but did not appear to influence IL-2 
1422  CD54 and MHC II Signaling in B Cells Table  1.  CD40 Ligation Induces B Cell Proliferation 
Experiment  No addition  + CD8ot-CD40-L  SI" 
1  240  +_  30  3,530  -+  270  15 
2  190  _+  5  3,280  _+  130  17 
3  70  +-  15  1,460  +_  230  20 
4  60  _+  10  905  _+  65  16 
Small resting B cells were either cultured alone (No addition) or with 
the CD8ot-CD40-L soluble construct in presence of biotinylated anti- 
CD8~ and streptavidin (+ CD8c~-CD40-L). [3H]Thymidine  incorpora- 
tion was measured at 2 d. Results  are shown as means of triplicate cul- 
tures (cpm _+ SD). 
* SI, Stimulation  index. 
responsiveness.  These  results  therefore demonstrate com- 
plementarity between contact ligands in signaling during T 
help for B cell activation. 
Discussion 
We have shown that MHC II and CD54 ligation induces 
IL-2R expression on B cells and responsiveness to IL-2. Our 
results indicate interdependence between contact signaling 
molecules that play a role in T-dependent B cell activation. 
Whereas cross-linking ligation of CD40 induced thymidine 
incorporation, and blocking CD40 strongly inhibited a wide 
range of B cell responses,  MHC II and CD54 ligation had 
weak effects on thymidine incorporation.  Coligation of MHC 
II with CD54 induced surface phenotype changes similar to 
those induced through CD40, consistent with B cell activa- 
tion. This shows a signaling role for CD54 and MHC II that 
could complement help provided through CD40 ligation. 
Although the evidence to date (including this study) identifies 
CD40 as a critical contact ligand, our results show that CD40 
blockade did not inhibit MHC II upregulation by activated 
Th contact, and did not totally inhibit proliferation, from 
which it can be inferred that CD40 is not the sole ligand 
for B cell activation. It was on this basis and because of our 
own previous results showing a role for CD54 and MHC 
II in T help that we compared CD54 and MHC II with CD40 
as ligands in contact help. 
The system that we have studied, in which a Thl clone 
induces Ig secretion by resting B cells, may be considered 
to mimic the cellular contact events that occur during cog- 
nate T-B interaction. A  role for Thl helpers  in protective 
antibody responses  has been shown in a variety of in vitro 
and in vivo systems (56).  In our system, induction of B cell 
proliferation occurs independently of cytokines, whereas Ig 
secretion is both contact and cytokine (IL-2) dependent (6-8). 
This allows us to study the induction of IL-2 responsiveness 
by B cells, given the inability of resting B cells to respond 
to this cytokine (53). Our own studies have shown upregu- 
lation of IL-2tL proteins during B cell activation, and we have 
also  shown  a  requirement  either  for  synergy with  Th2 
cytokines or for continued contact for the maintenance of 
a functional receptor (reference 53, and Poudrier, J., and T. 
Owens, unpublished observations). The present study identi- 
fies the B cell surface molecules CD54 and MHC II, both 
ligated during contact with activated  Thl, as signal  trans- 
ducing ligands for IL-2R upregulation. 
It is of particular interest that CD40 ligation did not in- 
duce functional IL-2R, whereas MHC II and CD54 did. Tech- 
nical reasons  for this discrepancy  are unlikely, since CD40 
ligation by a number of approaches was equally unsuccessful, 
including using anti-CD8 coupled to Sepharose beads to cross- 
link CD8ot-CD40-L, thereby mimicking the optimal con- 
ditions for MHC II and CD54 effect.  In a separate  study 
we have shown that very low levels of IL-2tLB were sufficient 
to induce responses to IL-2, provided that IL-2Ra was ade- 
quately induced (53). In this study, IL-2Rot was weakly in- 
duced by CD40 cross-linking,  but IL-2P,  q8 was undetectable. 
The resultant level of heterodimeric IL-2 receptor was obvi- 
ously insufficient for response.  CD40 appears most potent 
at transducing signals  for proliferation, as indicated by its 
unique ability to induce thymidine incorporation, but other 
signals are required for IL-2-dependent B cell differentiation 
into an Ig-secreting cell. Since B cell proliferative  responses 
do not require a functional IL-2R, the inability of CD40 
to induce this molecule would not impinge on its role in 
inducing proliferation. MHC II and CD54 may therefore be 
distinguished from CD40 on the basis of their involvement 
in IL-2-dependent differentiation to Ig secretion. 
In studies with human B cells, signaling through CD40 
synergized with a number of cytokines, including IL-2, IL-4, 
and  IL-10,  to  induce IgG  secretion  (57).  However,  it  is 
noteworthy that neither IL-2 nor IL-10 synergized with CD40 
when murine B cells were studied (58), consistent with our 
observations. We have confirmed that IL-4 promotes Ig secre- 
tion by murine B cells that had been stimulated with CDSot- 
CD40-L (Poudrier, J., unpublished observations).  There are 
two points that require emphasis. The first is the fundamental 
distinction between Thl and Th2 cytokines, whereby resting 
B cells express receptors  for and respond to IL-4 and IL-5, 
but show no response to IL-2. Our study exploits this all-or- 
none situation to identify contact ligands that are involved 
in the IL-2-dependent IgG production that is a feature of 
this Thl helper system. The second point concerns the mode 
of presentation of CD40-Ls to B cells. In the majority of 
studies,  CD40-L and anti-CD40 mAbs have been presented 
either via transfection of cell lines (20),  or through associa- 
tion with FcR+ cells (27, 59). This has the potential to pro- 
foundly influence B cell response. We have shown that mu- 
rine L cells secrete soluble factor(s) that synergize with IL-2 
to induce murine B cells to express IL-2R and to produce 
IgG, although supernatants had no effect by themselves (32). 
Analogous effects of CV1-EBNA or L cells may have con- 
tributed to CD40-dependent IgG secretion in studies where 
these were used (20,  59). 
Related to this, when CD40-Ls are presented on a cell sur- 
face, other ligands might also contribute to intercellular sig- 
naling. The proliferative responses  that we obtained with 
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ISis] with lower backgrounds) to those obtained by Lane et 
al. (26) who used the same construct. In their study, anti- 
Ig-Sepharose  further  amplified  responses  by  10-20-fold. 
Significantly,  the  same  construct  only  induced  threefold 
proliferative responses by human B cells, which were enhanced 
to sixfold by anti-IgD (26). This contrasts with results from 
Armitage et al. (57), who induced 20-fold or greater prolifer- 
ative responses in human B cells by CV1-EBNA cells trans- 
fected with  either human or mouse CD40-L.  It becomes 
important  to consider reasons for such discrepancy in the 
proliferative responses of human B cells. Our results show 
soluble CD40-L to be insufficient to induce cytokine-depen- 
dent progression to Ig secretion. The ability of CD40 fig- 
naling to synergize with cytokines for differentiation to Ig 
secretion in other studies may reflect the complex plethora 
ofligand-counter-ligand interactions that accompany CD40 
ligation by transfected or FcR + cells.  Our previous results 
(31, 32) argue for a complementary role for adhesion mole- 
cules and MHC II in intercellular contact signaling.  Signaling 
through these and other nonpolymorphic molecules that have 
ligands on CV1-EBNA cells could account for the greater 
responses to CD40-L-transfected cells.  Our demonstration 
of induction of functional IL-2R expression through MHC 
II  and  CD54  ligation  lends  weight  to  and  provides  a 
mechanistic basis  for such interpretation. 
Finally, it should be kept in mind that both the absolute 
responses and the SI's obtained in thymidine incorporation 
assays using soluble CD40-L constructs and murine B cells 
by Lane et al. (26) and by ourselves were the same as or greater 
than those obtained by Armitage et al. (57). This might argue 
that CD40  signals  are sufficient for proliferative responses 
of routine B cells, independent of other ligands. Neverthe- 
less, synergy between ligands may contribute to the overall 
level of signaling during T  help. 
The lack of consensus as to whether CD54 and MHC II 
can transduce signals during T help for murine B cell activa- 
tion may relate in part to the assays used. Noelle et al. (19) 
found no inhibition by antibodies against CD54 or MHC 
II when RNA synthesis induced by Th contact was assayed. 
We have shown strong inhibition of Ig secretion, but only 
partial inhibition of thymidine incorporation (31), and in the 
present study, there was again disparity between effects of 
these mAbs in different assays. The fact that anti-CD54 and 
anti-MHC II inhibited the induction of IL-2R proteins is 
consistent with their strong effect on Ig secretion and their 
relative lack of effect on proliferation. The profound inhibi- 
tion by CD8ot-CD40-L  of IL-21L upregulation is not dis- 
cordant with its inability to induce a functional IL-2R through 
CD40 ligation. CD40 is probably necessary but not sufficient 
for IL-2 responses. Because cross-linking of every ligand tested 
had a stimulatory effect of one kind or another, mAb inhibi- 
tions can be taken to reflect blockade of signaling interac- 
tions. The cell clustering that is a hallmark of T-B coculture 
systems was not inhibited in our experiments, arguing against 
gross steric effects. Negative signaling through MHC II was 
excluded by the fact that anti-CD4 mAbs were inhibitory. 
The latter observation implicates CD4 as the ligand for MHC 
II, as predicted from studies showing adhesion mediated by 
this ligand-receptor pair (60).  Effects of anti-CD4 or anti- 
MHC II on T cell activation could be unequivocally excluded 
because T cells were paraformaldehyde-fixed, in contrast to 
previous studies using live T  cells. 
Our data extend observations by Watts et al.  (61)  that 
MHC-restricted T-B interactions induced B7 expression by 
transformed B cell lines and also confirm observations of MHC 
II induction of B7 by Kouvlova et al.  (62).  We show that 
B7 was induced in nontransformed B cells  through non- 
MHC-restricted T-B interaction, and by CD40 ligation, thus 
supporting Watts et al's (61) prediction that the CD40-L 
might contribute to B7 induction. The level of B7 upregula- 
tion on B cells was directly proportional to concentrations 
of anti-V~/8 used to activate the T cells (Poudrier, J., unpub- 
lished observations). We have thus shown that T-B contact 
can induce B7 via at least two signaling pathways. CD40 li- 
gation was also implicated in B7 induction by Ranheim and 
Kipps (27). We have further resolved the question of whether 
MHC II signals for B7 induction, by dissociating a role for 
MHC II in induction of T cell activation vs. a signaling role 
for B cells. More directly, we have been able to induce B7 
by cross-linking MHC II with biotinylated mAb and strep- 
tavidin. Our own and Watts et al's data argue that only preac- 
tivated T  cells should be effective in B7 induction, so that 
T-dependent induction of B7 will occur relatively late in the 
response. This is consistent with a model for T-B interaction 
in which the primary signal for B7 induction on B cells is 
surface Ig  (slg)  ligation  (63),  which facilitates  the initial 
B-dependent T cell response. Primary T cell activation prob- 
ably occurs through recognition of antigen on non-B cell 
APC (7), which may reduce the threshold T cell dependence 
on B7 costimulation for subsequent response. During T-B 
contact, TCR-CD4 interaction with MHC II then delivers 
signals that simultaneously upregulate CD40-L on the T cell, 
and through MHC II/CD54 co-cross-linking upregnlate B7 
and MHC II on the B cell. The CD40-L-CD40  interaction 
further enhances B7 upregulation. Cross-talk between ligands 
is indicated by the fact that ligation of CD40 and CD54 up- 
regulated MHC II, CD40 and MHC II ligation upregulated 
CD54,  and CD54 and MHC II coligation upregulated B7 
as strongly as did CD40. These molecular upregulations serve 
to strengthen the cellular interaction and so augment subse- 
quent signaling. 
Can these noncognate ligands bypass a role for antigen in 
B cell activation? Although CD54 ligation could in prin- 
ciple occur independently of antigen recognition, LFA-1 on 
T cells may require activation for effective signaling (34). Fur- 
thermore, our data show that CD54 ligation alone only up- 
regulates MHC II. Similarly, MHC II ligation may occur 
whenever B cells encounter a CD4-bearing cell. But, our use 
of cross-linking mAbs might have amplified MHC II sig- 
naling beyond what is normally achieved through CD4 liga- 
tion, and TCR-MHC II interactions are probably more effec- 
tive.  Also, as for CD54,  MHC II cross-linking alone does 
not itself drive functional responses, but induces B7 upregu- 
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B7 expression by B cells is not sufficient to upregulate CD40-L 
expression  by T  cells, either alone or in conjunction with 
suboptimal anti-TcK stimulation (Poudrier, J., unpublished 
observations).  Coaggregation of these ligands induces func- 
tional cytokine receptors, but only through synergy with other 
cytokines, and so is dependent on T  cell activation for sig- 
naling, and effectively predisposes  to receipt  of help. T cells 
that are sufficiently  activated to produce cytokines would also 
express CD40-L, whose effects would overshadow those of 
MHC II and CD54. Effective cytokine production probably 
only occurs at short range, e.g., through cognate T-B inter- 
action. Bystander activation may occur by this complex of 
signals,  and this in fact is what our in vitro experimental 
system induces. 
The signaling role that MHC II and CD54 play is analo- 
gous to but distinct from the central role played by CD40. 
This raises the possibility that CD54 and MHC II could con- 
stitute a CD40-independent pathway of B cell activation. This 
might operate during interaction with cells that do not ex- 
press the CD40 ligand, such as FDC. We have shown the 
ability of CD54 to synergize with cytokines. Both of these 
stimuli are present in the germinal center and may contribute 
to the generation of high affinity Ab responses  and B cell 
memory. 
A synthesis of our and other results would suggest that 
proliferation in the germinal center (64) is primarily a slg- 
dependent event, which precedes and is necessary for subse- 
quent affinity maturation and generation of memory. This 
is dependent on T-B interaction during which the contact 
ligands that we have described contribute to further prolifer- 
ation, as well as induction and maintenance of cytokine re- 
sponsiveness. By linking levels of functional expression of adhe- 
sion/accessory molecules to the state ofT and B cell activation 
the immune response has exploited lymphocyte cell biology 
to control the antigen specificity of the antibody response. 
We acknowledge the excellent technical assistance  provided by Diane Heath. We thank Drs. P. Lane (Basel 
Institute for Immunology) for generous provisions of a CDSa-CD40-L secreting hybridoma, P. Linsley 
(Bristol Myers Squibb), and M. Kehry (Boehringer Ingelheim Corp.) for purified CTLA4- and CD40- 
HulgG constructs; M. Miyasaka and T. Tanaka (Tokyo Metropolitan Institute of Science) for purified 
TM/31 mAb; Dr. T. Mosmann and Dr. K. Coffman for hybridomas; and Dr. M. Ratcliffe and Dr. T. 
Renno for comments on the manuscript. 
This work was supported by a grant to T. Owens from the Medical Research Council of Canada. T. 
Owens was supported by a Medical Research Council Scholarship.  J. Poudrier was supported by a fellow- 
ship from the Fonds de Recherche en Sant6 du Quebec (FKSQ). 
Address correspondence to Dr. Trevor Owens, Neuroimmunology Unit, Montreal Neurological Institute, 
3801 University Street, Montr6al, Quebec, Canada H3A 2B4. 
Received for publication 30 August  1993 and in revised  form  12 January  1994. 
References 
1.  Lanzavecchia,  A. 1985. Antigen-specific  interaction between 
T and B cells. Nature (Lond.). 314:537. 
2.  Tony, H.-P., and D.C. Parker. 1985. Major histocompatibility 
complex-restricted polyclonal  B cell responses resulting from 
helper T cell recognition of antiimmunoglobulin presented  by 
small B lymphocytes.  J. Exlx Med. 161:223. 
3.  Chesnut, R..W., and H.M. Grey. 1986. Antigen presentation 
by B cells  and its significance  in T-B interactions.  Adv. Immunol. 
39:51. 
4.  Noelle, R.J., C.J. Snow,  J.W. Uhr, and E.S. Vitetta. 1983. Ac- 
tivation of antigen-specific  B cells: role of T cells, cytokines, 
and antigen in induction of growth and differentiation. Proc. 
Natl. Acad. Sci. USA.  80:6628. 
5. Julius, M.H., H. yon Boehmer, and C.L. Sidman. 1983. Dis- 
sociation of two signals required for activation of resting B 
cells. Proc. Natl. Acad. Sci. USA.  79:1989. 
6.  Parker, D.C. 1993. T cell-dependent B-cell activation. Annu. 
Rev. Immunol. 11:331. 
7.  Owens, T. 1990. Cellular contact as a component of signaling 
during cognate T/B interactions. In 32nd Forum in Immu- 
nology: How Does the Helper T Cell Activate the Resting 
B Cell When It Recognizes Antigen on the B-cell Surface? 
D.C. Parker, editor. Res. Immunol. 141:417. 
8.  Noelle, R.J., and E.C. Snow. 1990. Cognate interactions be- 
tween helper T cells and B cells. Immunol. Today. 11:361. 
9.  Owens,  T. 1988. A non-cognate interaction with anti-receptor 
antibody-activated  helper T cells induces small resting B cells 
to proliferate and to secrete antibody. Eur.J. Immunol. 18:395. 
10.  Owens,  T. 1991. Requirement for noncognate interaction with 
T cells for the activation of B cell immunoglobulin secretion 
by IL-2. Cell. Immunol. 133:352. 
11.  DeFranco,  A.L., J.D. AshweU,  K.H. Schwartz, and W.E. Paul. 
1984. Polyclonal stimulation  of resting  B lymphocytes by 
antigen-specific T lymphocytes.  J. Exp. ivied. 159:861. 
12. Julius, M.H., and H.-G.  Rammensee. 1988. T  helper cell- 
dependent induction of resting B cell differentiation need not 
require cognate cell interactions. Eur. J. Immunol. 18:375. 
13.  Whalen, B.J., H.-P. Tony, and D.C. Parker. 1988. Character- 
1425  Poudrier  and Owens ization of the effector  mechanism of help for antigen-presenting 
and bystander resting B cell growth mediated by Ia-restricted 
Th2 helper T  cell lines. J. Immunol.  141:2230. 
14.  Brian, A.  1988. Stimulation of B-ceU proliferation by mem- 
brane-associated molecules from activated T cells. Proc. Natl. 
Acad. Sci. USA.  85:564. 
15.  Hodgkin,  P.D.,  L.C.  Yamashita,  R.L. Coffman, and M.R. 
Kehry. 1990. Separation of events mediating B cell prolifera- 
tion and Ig production by using T cell membranes and lym- 
phokines. J. Immunol.  145:2025. 
16.  Noelle, R.J., D.M. Shepherd, and W.C. Bartlett. 1991. Cog- 
nate interactions between helper T cells and B cells. VI. Purified 
plasma membranes from activated helper T cells induce B cells 
into cell cycle entry and lymphokine responsiveness.J. Immunol. 
146:1118. 
17.  Krusemeier, M., and E.C. Snow. 1988. Induction oflymphokine 
responsiveness  of hapten-specific  B  lymphocytes promoted 
through an antigen-mediated  T helper lymphocyte interaction. 
j.  Immunol.  140:367. 
18.  Lederman, S., M.J. Yellin, A. Krichevsky, J. Belko, J.J. Lee, 
and L. Chess.  1992. Identification of a novel surface protein 
on activated CD4 § T cells that induces contact-dependent B 
cell differentiation (help). J. Exp.  Med.  175:1091. 
19.  Noelle, R.J., M. Roy, D.M. Shepherd, I. Stamenkovic, J.A. 
Ledbetter, and A. Aruffo. 1992. A 39-kDa protein on activated 
helper T cells binds CD40 and transduces the signal for cog- 
nate activation orb cells. Proc. Natl. Acad. Sci. USA. 89:6550. 
20.  Armitage, R.J., W.C. Fanslow, L. Strockbine, T.A. Sato, K.N. 
Clifford, B.M.  McDuff,  D.M.  Anderson,  S.D.  Gimpel,  T. 
Davis-Smith, C.R. Maliszewski,  et al. 1992. Molecular char- 
acterization  of a  murine ligand  for CD40.  Nature  (Lond.). 
357:80. 
21.  Lane, P., A. Traunecker,  S. Hubele, S. Inui, A. Lanzavecchia, 
and D. Gray. 1992. Activated human T cells express a ligand 
for the human B cell associated antigen CD40 which partici- 
pates  in T  cell-dependent activation of B lymphocytes. Eur. 
J. Immunol.  22:2573. 
22.  Korth~iuer, U., D. Graf, H.W. Mages, F. Bri~re, M. Padayachee, 
S. Malcolm, A.G. Ugazio, L.D. Notarangelo, R.J. Levinsky, 
and R.A. Kroczek. 1993. Defective expression of T-cell CD40 
ligand causes X-linked immunodeficiency  with hyper-IgM. Na- 
ture (Lond.). 361:539. 
23.  DiSanto, J.P., J.Y. Bonnefoy, J.F. Gauchat, A. Fischer, and G. 
de Saint Basile. 1993. CD40 ligand mutations in X-linked im- 
munodeficiency with hyper-IgM. Nature (Lond.), 361:541. 
24.  Allen, R.C., R.J. Armitage, M.E. Conley, H. Rosenblatt,  N.A. 
Jenkins, N.G. Copeland, M.A. Bedell, S. Edelhoff, C.M. Dis- 
teche, D.K. Simoneaux, et al. 1993. CD40 ligand gene defects 
responsible for X-linked hyper-IgM syndrome. Science (Wash. 
DC). 259:990. 
25.  Aruffo,  A.,  M.  Farrington,  D.  Hollenbaugh,  X.  Li,  A. 
Milatovich,  S.  Nonoyama, J.  Bajorath,  L.S.  Grosmaire, R. 
Stenkamp, M. Neubauer, et al. 1993. The CD40 ligand, gp39, 
is defective in activated T  cells from patients with X-linked 
hyper-IgM syndrome. Cell. 72:291. 
26.  Lane, P., T. Brocker, S. Hubele, E. Padovan, A. Lanzavecchia, 
and E McConnell. 1993. Soluble CD40 ligand can replace the 
normal T  cell-derived CD40  ligand  signal  to B cells in  T 
cell-dependent activation, j.  Exp.  Med.  177:1209. 
27.  Ranheim, E.A., and T.J. Kipps. 1993. Activated T cells induce 
expression of B7/BB1 on normal or leukemic B cells through 
a CD40-dependent signal. J. Exp.  Med.  177:925. 
28.  Liu, Y.-J., D.E. Joshua, G.T. Williams, C.A. Smith, J. Gordon, 
and I.C.M. MacLennan.  1989. Mechanism of antigen-driven 
selection  in germinal centres.  Nature (Lond.). 342:929. 
29.  Hodgkin, P.D., and M.R.  Kehry.  1992. B cell activation  by 
T  cells - the "TICCE' model.  The Immunologist.  1:5. 
30.  Roy, M., T. Waldschmidt, A. Aruffo, J.A. Ledbetter, and R.J. 
Noelle. 1993. The regulation of the expression of gp39,  the 
CD40 ligand,  on normal and cloned CD4 § T  cells, j.  Im- 
munol.  151:1. 
31.  Owens,  T.  1991. A role for adhesion  molecules  in contact- 
dependent T  help for B cells. Eur. J. lmmunol.  21:979. 
32.  Owens, T., D. Heath, andJ. Poudrier.  1993. Synergy between 
cell contact and cytokines in B cell activation.  Advances in Mo- 
lecular and Cellular Immunology.  1B:51. 
33.  Ledbetter, J.A., C.H. June, L.S. Grosmaire,  and P.S. Rabino- 
vitch. 1987. Crosslinking of surface antigens causes mobiliza- 
tion of intracellular  ionized calcium in T lymphocytes.  Proc. 
Natl. Acad. Sci. USA.  84:1384. 
34.  Figdor, C.G., Y. van Kooyk, and G.D. Keizer. 1990. On the 
mode of action of LFA-1. Immunol.  Today, 11:277. 
35.  Lane, P.J.L.,  F.M.  McConnell, E.A.  Clark,  and E. Mellins. 
1991. Rapid signaling  to B cells by antigen-specific T ceils re- 
quires  CD18/CD54 interaction. J.  Immunol.  147:4103. 
36.  St.-Pierre, Y., N. Nabavi, Z. Ghogawala,  L.H. Glimcher, and 
T.H. Watts.  1989. A functional role for signal transduction 
via the cytoplasmic domains of MHC class II proteins, j. Im- 
munol.  143:808. 
37.  Cambier, J.C.,  and K.R.  Lehman.  1989. Ia-mediated  signal 
transduction leads to proliferation of primed B lymphocytes. 
J. Exp.  Med.  170:877. 
38.  Staerz,  U.D.,  H.G.  Rammensee, J.D.  Benedetto, and M.J. 
Bevan. 1985. Characterization of a murine monoclonal anti- 
body specific for an allotypic determinant on T cell antigen 
receptor, j.  Immunol.  134:3994. 
39.  Ledbetter, J.A., and L.A. Herzenberg. 1979. Xenogeneic mono- 
clonal antibodies  to mouse lymphoid differentiation antigens. 
Immunol.  Rev. 47:63. 
40.  Lake, P., E.A. Clarke, M. Korshidi, and G.H. Sunshine.  1979. 
Production and characterization of cytotoxic Thy-1 antibody- 
secreting hybrid cell lines. Detection of T cell subsets. Eur. J. 
Immunol.  9:875. 
41.  Tomonari, K., E. Loverng, and S. Spencer. 1990. Correlation 
between the V~4 CD8 § T-cell population and the H-2  d haplo- 
type. Immunogenetics. 31:333. 
42.  Coffman, R.L., B.W.P. Seymour, S. Hudak, J. Jackson, and 
D. Rennick. 1989. Antibody to interleukin-5 inhibits helminth- 
induced eosinophilia  in mice. Science (Wash. DC).  245:308. 
43.  Ceredig, R., J.W.  Lowenthal, M. Nabholz, and H.R.  Mac- 
Donald.  1985. Expression  of interleukin-2  receptors  as  a 
differentiation marker on intrathymic stem cells. Nature (Lond.). 
314:98. 
44.  Raulet, D.H., P.D. Gottlieb, and M.J. Bevan. 1980. Fraction- 
ation of lymphocyte populations with monoclonal antibodies 
specific for Lyt-2.2 and Lyt-3.1. J. Immunol.  125:1136. 
45.  Tanaka, T., M. Tsudo, H. Karasuyama, F. Kitamura, T. Kono, 
M. Hatakeyama, T. Taniguchi, and M. Miyasaka. 1991. A novel 
monoclonal antibody against  murine IL-2 receptor/~-chain. 
Characterization of receptor expression  in normal lymphoid 
cells and EL-4 cells. J. Immunol.  147:2222. 
46.  Leo, O., M. Foo, D.H. Sachs, L.E. Samelson, and J.A. Blue- 
stone.  1987. Identification of a monoclonal antibody specific 
for a  routine  T3  polypeptide. Proa Natl.  Acad.  Sci. USA. 
84:1374. 
47.  Mosmann, T.R., H. Cherwinski, M.W. Bond, M.A. Giedlin, 
1426  CD54 and MHC II Signaling in B Cells and K.L. Coffman. 1986. Two types of murine helper T cell 
clone. I. Definition according to profiles  of lymphokine ac- 
tivities and secreted  proteins. J. lmmunol.  136:2348. 
48.  Dialynas, D.P.,  F.S. Quan,  K.A.  Wall,  A.  Pierres,  J.  Quin- 
tano, M.A. Loken, M. Pierres, and F.W. Fitch. 1983. Charac- 
terization  of the  murine  T  cell  molecule  designated  L3T4 
identified by monoclonal antibody GK1.5. Similarity of L3T4 
to human Leu3/T4  molecule. J.  Irnmunol.  131:2445. 
49.  Momburg, F., N. Koch, P.  Moeller,  G. Moldenhauer,  G.W. 
Butcher, and G.J. Hammerling. 1986. Differential expression 
of Ia and Ia-associated  invariant chain in mouse tissues  after 
in vivo treatment with IFN-y. J.  Immunol.  136:940. 
50.  Horley, K.J., C. Carpentino, B. Baker, and F. Takei. 1989. Mo- 
lecular  cloning  of  murine  intercellular  adhesion  molecule 
(ICAM-1). EMBO J.  8:2889. 
51.  Linsley, P.S., W. Brady, M. Urnes, L.S. Grosmaire, N.K. Damle, 
and J.A. Ledbetter. 1991. CTLA-4 is a second receptor for the 
B cell  activation antigen  B7. J. Exp.  Med. 174:561. 
52.  Karasuyama, H., and E Melchers. 1988. Establishment of mouse 
cell lines which constitutively secrete large quantities of inter- 
leukin 2, 3, 4, or 5, using modified cDNA expression vectors. 
Eur. J.  Immunol.  18:97. 
53.  Poudrier, J., and T. Owens. 1994. The acquisition of cytokine 
responsiveness  by  murine  B  cells:  a  role  for  antigen  and 
interleukin-5 in the induction of interleukin-2 receptors. Im- 
munology. 81:373. 
54.  Malek, T.R., R.J. Kobb, and E.M. Shevach. 1983. Identification 
and initial characterization of a rat monoclonal antibody reac- 
tive with the routine interleukin 2 receptor ligand complex. 
Proc. Natl. Acad. Sci. USA.  80:5694. 
55.  Loughnan, M.S., K. Takatsu,  N. Harada, and G.J.V. Nossal. 
1987. T-cell-replacing factor (interleukin 5) induces expression 
ofinterleukin 2 receptors on murine splenic B cells. Proc. Natl. 
Acad. Sci. USA.  84:5399. 
56.  Mosmann, T.K., and K.L. Coffman. 1989. TH1 and TH2 cells: 
different patterns of lymphokine secretion lead to different func- 
tional properties. Annu.  Rev. lmmunol.  7:145. 
57.  Armitage,  R.J.,  B.M.  Macduff,  M.K.  Spriggs,  and  W.C. 
Fanslow.  1993. Human B cell proliferation and Ig secretion 
induced by recombinant CD40 ligand are modulated by soluble 
cytokines, j.  lmmunol.  150:3671. 
58.  Maliszewski, C.R.., K. Grabstein,  W.C. Fanslow, R. Armitage, 
M.K. Spriggs, and T.A. Sato. 1993. Recombinant CD40 ligand 
stimulation of murine B cell growth and differentiation: cooper- 
ative effects  of cytokines. Eur. J.  Immunol.  23:1044. 
59.  Saeland,  S., V. Duvert, I. Moreau, and J. Banchereau.  1993. 
Human B cell precursors proliferate and express  CD23 after 
CD40 ligation. J. Exp.  Med. 178:113. 
60.  Doyle, C., andJ.L. Strominger.  1987. Interaction between CD4 
and class II MHC molecules mediates cell adhesion. Nature 
(Lond.). 330:256. 
61.  Watts, T.H., N. Alaverdi,  W.F. Wade, and P.S. Linsley. 1993. 
Induction of costimulatory molecule B7 in M12 B lymphomas 
by cAMP or MHC-restricted T  cell interaction. J. Immunol. 
150:2192. 
62.  Kouvlova, L., E.A. Clark, G. Shu, and B. Dupont. 1991. The 
CD28 ligand B7/BB1 provides a costimulatory signal for al- 
loactivation of CD4 § T  cells. J. Exp.  Med.  173:759. 
63.  Freedman,  A.S.,  G. Freeman, J.C.  Horowitz, J.  Daley,  and 
L.M. Nadler. 1987. B7, a B-cell-restricted antigen that identifies 
preactivated B cells, j.  Immunol.  139:3260. 
64.  Szakal, A.K., M.H. Kosco, andJ.G. Tew. 1989. Microanatomy 
of lymphoid tissue during humoral immune responses:  struc- 
ture function  relationships. Annu.  Rev. Immunol.  7:91. 
1427  Poudrier  and Owens 